1Ferrara F, Palmieri S, Mele G. Prognostic factors and therapentic options for relapse or refractory acute myeloid leukemia. Haematologica, 2004, 89:998- 1008.
2Tallman M, Nabhan C. Managent of acute promyelocytic leukemia. Curr Oncol Rep, 2002, 4:381-389.
3Fenaux P, Chastang C, Chevret S, et al. A randomized comparise of all-trans retinoic acute promyelocytix leukemia. The Europea APL Group. Blood, 1999, 94:1192-1200.
4Fenaux P, Chevret S, Guerci A, et al. Long-term follow-up confirms the benefit of all-trans retinoic acid in acute promyelocytic leukemia. Leukemia, 2000, 14:1371-1377.
5Ohno R, Asou N, Ohnishi K, et al. Treatment of acute promyelocytic leukemia: strategy toward further increase of cure rate. Leukemia, 2003, 17:1454-1463.
